SintLab

Diversification of a Novel α‐Galactosyl Ceramide Hotspot Boosts the Adjuvant Properties in Parenteral and Mucosal Vaccines - Angewandte Chemie International Edition - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/an…

As the UN discuss Ukraine, which is important to global security, a much bigger threat is increasing in the world that is the interaction between climate change and epidemics - a good and sad example is how two extreme events in Pakistan and Malawi fuelled the world worst cholera epidemic -devex.com/news/how-pakis… Libya may be at danger of a new Cholera epidemic and we urge the world to act until is late.

Merging Solid-Phase Peptide Synthesis and Automated Glycan Assembly to Prepare Lipid-Peptide-Glycan Chimeras (Peter H. Seeberger and co-workers) @ManuelG_Ricardo @peterseeberger @MpiciPotsdam onlinelibrary.wiley.com/doi/10.1002/ch…

El Proyecto @GLACIERDAAD es una iniciativa que bajo la estrecha colaboración de varias instituciones se participa en la atención sanitaria a la prevención y control de pandemias. Desde Cuba participa: @SintLabUH, @CIDEM_Cuba @FinlayInstituto @MINSAPCuba @FundacionUH

Soberana 02 and Soberana Plus protein-based COVID-19 vaccines show promising immunogenicity, efficacy and safety profiles in a multicenter randomized double-blind, placebo-controlled, phase 3 trial in Iran. @Pasteur_Iran @FinlayInstituto #Pastocovac ja.ma/421avH0

Visiting the University of Bielfeld @unibielefeld, and sharing ideas with Norbert Sewald and his amazing group of students. More on peptide-drug conjugates in the #magicbulletreloaded symposium.

Most people from the so-called 'Global South' cannot travel to Europe because European governments believe that COVID-19 vaccines developed in our countries are not good enough. This is technological racism, it is a continuation of the same racism by new means.

Accurate de novo design of membrane-traversing macrocycles cell.com/cell/fulltext/…

A nice and complete interactive overview on the five different SARS-CoV-2 Cuban Public vaccines (and candidates) @cubadebatecu Immense work and achievements for @BioCubaFarma @FinlayInstituto @CIGBCuba @centro_cim Thanks for all that! interactivos.cubadebate.cu

One of the most beatiful readings ever made. Enjoy. journals.asm.org/doi/10.1128/mb…

Ya está disponible el Episodio 2 de nuestro podcast 🎙 Reacción en Cadena titulado "Vacunas y universidad - Entrevista a Daniel García" Encuéntranos en tus plataformas de podcast favoritas cada 15 días Produce: @NexosMultimedia ¿Cómo escucharnos? En el siguiente tuit 👇

@rsc_chembio @Daniel_G_Rivera @SintesisLab @FinlayInstituto Artículo sobre el desarrollo e inmunogenicidad del candidato vacunal cubano Soberana01. Resultado del @FinlayInstituto en colaboración con @centro_cim, @SintLabUH de @UdeLaHabana y otras instituciones nacionales e internacionales.

🔥 New advance article for RSC Chemical Biology! 🔥 @Daniel_G_Rivera et al @SintesisLab @FinlayInstituto with a #COVID-19 vax candidate composed of virus' RBD dimer & Neisseria meningitidis outer membrane vesicles #chembio 🧐Read the #OpenAccess article 👉ow.ly/r5ig50Hw0Ko

Happy to share this article on the development of a new COVID-19 vaccine candidate, soon to be approved for emergency use in Cuba. It will be a powerful asset in the fight against Omicron in the upcoming months. pubs.rsc.org/en/Content/Art…

#Soberana02 comenzó su aplicación como dosis de refuerzo en la provincia de #SantiSpiritus. Combinación heterologa en adultos previamente vacunados con #Abdala. @FinlayInstituto @saludsspiritus

Indeed it was a clever bet, we always said it, we need our own vaccines. #Soberana is a tremendous success. Cuba’s bet on home-grown COVID vaccines is paying off nature.com/articles/d4158…

26 million doses of Cuban SARS-CoV-2 protein-based vaccines administred are not enough to be mentioned @Nature by @ElieDolgin. With different peer-reviewed articles accepted, others on medRxiv and with already different citations on key reviews around... Please...

Alianza Universidad-Empresa @EduardoCim @BioCubaFarma @UdeLaHabana

Fruto de la alianza estratégica entre el @FinlayInstituto, el Centro de Inmunología Molecular y la @UdeLaHabana se firma el primer contrato para la comercialización de productos en el cual interviene la UH @CubaMES @nicado3 @uhcuba @BioCubaFarma @cubacecmed @CIGBCuba @jsaborido50

Ensayo fase III en Irán con #Soberana02 confirma los resultados obtenidos en Cuba, con un predomina de variable delta en el país persa. #VamosBien #VacunaCOVID19 @FinlayInstituto @centro_cim @UdeLaHabana.

Confirman los resultados de Ensayo Clínico Fase III desarrollado por el Instituto Pasteur de Irán eficacia de vacunas #SOBERANA02 y #SOBERANAPlus frente a la cepa Delta. #VacunasCubanasCovid19